{"id":"W1532234313","doi":"10.1111/jth.12005","title":"Comparative effectiveness and safety of the novel oral anticoagulants: do the pivotal clinical trials point to a new paradigm?","year":2012,"lang":"en","type":"letter","venue":"Journal of Thrombosis and Haemostasis","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"National Heart, Lung, and Blood Institute; U.S. Food and Drug Administration; University of Colorado; National Institutes of Health; Center for Plant Conservation","keywords":"Rivaroxaban; Medicine; Dabigatran; Antithrombotic; Clinical trial; Dosing; Warfarin; Direct thrombin inhibitor; Apixaban; Vitamin K antagonist; Intensive care medicine; Ximelagatran; Pharmacology; Internal medicine; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04645474,0.0009200918,0.006475878,0.001292374,0.001334582,0.004624937,0.004289676,0.02696823,0.006190801],"category_scores_gemma":[0.2455267,0.0007380979,0.002711846,0.002601053,0.005397845,0.008100536,0.001455895,0.02391203,0.002471063],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004053025,"about_ca_system_score_gemma":0.004336459,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001291477,"about_ca_topic_score_gemma":0.002410755,"domain_scores_codex":[0.9608199,0.02176123,0.007251421,0.002732076,0.006494892,0.000940439],"domain_scores_gemma":[0.5889348,0.367083,0.01722494,0.005525759,0.01539776,0.005833644],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","study_design_scores_codex":[0.01599525,0.0006351613,0.01456705,0.004334612,0.002854686,0.004169627,0.0005184376,0.0008455078,0.001258266,0.03187419,0.6703714,0.252576],"study_design_scores_gemma":[0.02535423,0.004959614,0.02055747,0.007982947,0.004680433,0.01207556,0.002064685,0.004181972,0.002221834,0.2161396,0.699073,0.0007085843],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.003379171,0.02809998,0.0005507225,0.9497592,0.01544142,0.00003298933,0.0002417222,0.00002108044,0.002473693],"genre_scores_gemma":[0.03474809,0.01567447,0.00180174,0.7945468,0.1520984,0.0001184447,0.0001911684,0.00002798999,0.0007928156],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.04645474,"threshold_uncertainty_score":0.2456791,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3972137141265196,"score_gpt":0.4869591324557774,"score_spread":0.08974541832925775,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}